The evolving continuum of dysglycaemia: Non-diabetic hyperglycaemia in older adultsGolding J, Hope S, Chakera A and  Puttana ADiabet Med. 2023 Oct;40(10):e15177.https://doi.org/10.1111/dme.15177

Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves β-Cell FunctionHerold K, Gitelman S, Gottlieb P, Knetch L, Raymond R, and Ramos EDiabetes Care. 2023 Oct 1;46(10):1848-1856https://doi.org/10.2337/dc23-0675